$UHT

Universal Health Realty Income Trust reports Q2 net income $5.9M; adjusted EPS $0.37

Universal Health Realty Income Trust (UHT) reported Q2 2026 net income of $5.9M, or $0.43 diluted EPS, and adjusted net income of $5.2M, or $0.37 adjusted EPS, excluding a $724k land sale gain. Q2 FFO was $12.5M, or $0.90 per share. The firm also increased credit capacity to $475M and reported $109.4M available at June 30, 2026.

Original reporting
Published Jul 27, 2026, 8:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 9:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Universal Health Realty Income Trust reports Q2 net income $5.9M; adjusted EPS $0.37 — source image
Decision brief

The 30-second read

$UHTNeutralMed
01

Why it matters

Traders can reassess near-term earnings quality (net income vs adjusted net income and FFO) and balance-sheet flexibility (available borrowing capacity) based on the disclosed figures and financing amendment.

02

Market read

This is a primary earnings and financing update with concrete adjusted EPS and FFO figures, plus expanded borrowing capacity that can influence valuation and credit-risk perception.

03

What to watch

The master flex lease coverage (~75% of rentable square feet) and third-party lease reductions could affect future cash flows, but the article provides no sensitivity or occupancy/lease-rate details.

Relevance 6/10Novelty 6/10Timing: after-hours earnings update for quarter ended June 30, 2026

Background

The company reported Q2 2026 results and highlighted a land sale, a credit facility amendment, and progress on a medical office development tied to a UHS subsidiary.

Company-level read

Ticker impact

$UHTNeutralMedium confidence
Context

Universal Health Realty Income Trust reported Q2 2026 net income of $5.9M and adjusted EPS of $0.37, plus a credit facility capacity increase to $475M.

Expected impact

Likely modest, with direction dependent on how the market values FFO versus adjusted earnings and the significance of the $475M capacity increase.

Evidence & confidence

The article is a primary SEC-based earnings update with specific datapoints (net income, adjusted EPS, FFO) and a concrete financing amendment, but it lacks guidance, consensus context, or a major one-off beyond the land sale gain.

Market effects

Adds incremental data on REIT property-level monetization (land sale) and financing flexibility, relevant to healthcare real estate peers’ credit and FFO quality assessments.

Chicago land sale proceeds are a localized datapoint, but the article does not indicate broader regional demand shifts.

Limited, as the news is company-specific and US-focused.

Counterpoint

Adjusted EPS excludes a land-sale gain, so the headline net income strength may not translate into sustainable operating earnings power.

Key entities

  • Universal Health Realty Income Trust

    Reported Q2 2026 net income, adjusted EPS, FFO, and disclosed a credit facility capacity increase plus a land sale gain.

  • UHS subsidiary

    Entered a ground lease for the Miller Medical Plaza development and will hold a 10-year master flex lease for about 75% of rentable space.

Related articles

$UHTMed

UNIVERSAL HEALTH REALTY INCOME TRUST (UHT): Results of Operations and Financial Condition

UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 uht-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 UNIVERSAL HEALTH REALTY INCOME TRUST Universal Corporate Center 367 S. Gulph Road P.O. Box 61558 King of Prussia, PA 19406 (610) 265-0688 FOR IMMEDIATE RELEASE CONTACT: Charles Boyle July 27, 2026 Chief Financial Officer (610)

$UNFIMedAI 8/10

United Natural Foods (UNFI) Calls the Bottom and Guides for Growth Again

United Natural Foods (UNFI) reported Q4 adjusted EPS of $0.69, beating estimates, but revenue of $7.64B missed expectations. The company guided fiscal 2027 sales to $31.2B-$31.8B, up from $31.15B in 2026. Adjusted EBITDA rose 27% to $701M, and free cash flow hit a record $323M. Management expects fiscal 2027 adjusted EPS of $3.00-$3.50. Hedge fund interest declined in Q2.

MedAI 8/10

LuxExperience B.V. Q4 2026 Earnings Call Summary

LuxExperience B.V. reported Q4 2026 earnings, highlighting EBITDA break-even 15 months post-acquisition. Mytheresa reached EUR 1 billion in sales, while NET-A-PORTER and MR PORTER returned to growth. YOOX cut losses by half. Management expects 2%-3% EBITDA margins in FY 2027 and EUR 4 billion in net sales by 2028. The company improved operational efficiency and strengthened its financial position.

$MOVMed

Movado’s Turnaround Gains Momentum

Movado Group (NYSE: MOV) reported two consecutive quarters of earnings beats, with shares up 60% year-to-date. Analysts rate it a Strong Buy, with an average price target of $40, implying 22% upside. The company benefited from tariff refunds and a shift in consumer preferences toward traditional watches. However, investors should consider potential margin pressures and competition from smartwatches.